Morning Market Losers
March 30, 2015 at 09:49 AM EDT
Can-Fite BioPharma Ltd. (NYSE: CANF) shares dipped 49.82% to $2.78 following news that top-line results from Phase II/III trial for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.